Thyroid carcinoma: Diagnostic and therapeutic approach; genetic background (review)

Endocrine Regulations

Volumn 34, Issue 2, 2000, Pages 99-113

  Lewinski, A ^a   Ferenc, T ^a   Sporny, S ^a   Jarzab, B ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Cytology; Genetic background; Pathomorphology; Thyroid cancer; Treatment

Indexed keywords

IODINE 131; LEVOTHYROXINE;

CANCER RADIOTHERAPY; HETEROZYGOSITY LOSS; METASTASIS; PATHOGENESIS; PROTO ONCOGENE; REVIEW; THYROID CANCER;

ADENOCARCINOMA, FOLLICULAR; CARCINOMA; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; DROSOPHILA PROTEINS; GENES, RAS; HUMANS; INSECT PROTEINS; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MET; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS;

EID: 0033840634     PISSN: 00137200     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. BONGARZONE I, MONZINI N, BORRELLO MG, CARCANO C, FERRARESI G, et al. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RIα of cyclic AMP-dependent protein kinase A. Mol Cell Biol 13,358-366,1993
2. BOTTARO DP, RUBIN JS, FALETTO DL, CHAN AML, KURIECK TE, et al. The hepatocyte growth factor receptor is the c-met proto oncogene product. Science 152,802-804,1991
3. BYRD DA, SWEET DJ, PANTE N, KONSTANTINOV KN, GUAN T, et al.Tpr, a large coiled coil protein whose amino terminus is involved in activation of oncogenic kinases, is localized to the cytoplasmic surface of the nuclear pore complex. J Cell Biol 127,1515-1526,1994
4. CHAN JKC. Tumors of the thyroid and parathyroid glands. In: Diagnostic Histopathology of Tumors (Ed CDM Fletcher), Vol. 2, pp. 705-763. Churchill Livingstone, Edinburgh 1995
5. DI RENZO MF, OLIVERO M, FERRO S, PRAT M, BONGARZONE I, et al. Overexpression of the c-Met/HGF receptor gene in human thyroid carcinomas. Oncogene 7,2549-2553,1992
6. FAGIN JA. Genetic basis of endocrine disease 3. Molecular defects in thyroid gland neoplasia. J Clin Endocrinol Metab 75,1398-1400,1992
7. FARID NR, SHI Y, Zou M. Molecular basis of thyroid cancer. Endocrine Rev 15,202-232,1994
8. FARID NR, Zou M, SHI Y. Genetics of follicular thyroid cancer. Endocrinol Metab Clin N Am 24,865-883,1995
9. FONSECA E, SOBRFNHO-SIMÖES M. Diagnostic problems in differentiated carcinomas of the thyroid. Path Res Pract 191,318-331,1995
10. FRANC B, ROSENBERG-BOURGPN M, CAILLOU B, DUTRIEUX-BERGER N, FLOQUET J, et al. Medullary thyroid carcinoma: search for histological predictors of survival (109 proband cases analysis). Hum Pathol 29,1078-1084,1998
11. FUGAZZOLA L, PIEROTTI MA, VIGANO E, PACINI F, VORONTSOVA TV, BONGARZONE I. Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes in a post-Chernobyl papillary thyroid cancer. Oncogene 13,1093-1097,1996
12. GANDINO L, MUNARON L, NALDINI L, FERRACINI R, MAGNI M, COMOGLIO PM. Intracellular calcium regulates the thyrosine kinase receptor encoded by the met oncogene. J Biol Chem 266,16098-16104,1991
13. GRECOA, MARIANI C, MIRANDA C, LUPAS A, PAGLIARDINI S, POMATI M, PIEROTTI MA. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain. Mol Cell Biol 15,6118-6127,1995
14. GRECO A, MIRANDA C, PAGLIARDINI S, FUSETTI L, BONGARZONE I, PIEROTTI MA. Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes. Genes Chrom Cancer 19,112-123,1997
15. GRECOA, PIEROTTI MA, BONGARZONE I, PAGLIARDINI S, LANZI A, DELLA PORTA G. Trk-T1 is a novel oncogene formed by the fusion of tpr and trk genes in human papillary thyroid carcinomas. Oncogene 7,237-242,1992
16. HERRMANN MA, HAY ID, BARTELT DH, RITLAND SR, DAHL RJ, GRANT CS, JENKINS RB. Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers. J Clin Invest 88,1596-1604,1991a
17. HERRMANN ME, TALPOS GB, MOHAMEDAN, SAXEA, RATNER S, LALLEY PA, WOLMAN SR. Genetic markers in thyroid tumors. Surgery 110,941-948,1991b
18. JENKINS RB, HAY ID, HERATII JF, SCHULTZ CG, SPURBECK JL, DEWALD G. Frequent occurrence of cytogenetic abnormalities in sporadic non-medullary thyroid carcinoma. Cancer 66,1213-1220,1990
19. JORDA M, GONZALEZ-CAMPORA R, MORA J, HERRERO-ZAPATERO A, OTAL C, GALERA H. Prognostic factors in follicular carcinoma of the thyroid. Arch Pathol Lab Med 117,631-635,1993
20. KARGA H, LEE J-K, VICKERY AL, THOR A, GAZ RD, JAMESON JL. Ras oncogene mutations in benign and malignant thyroid neoplasms. J Clin Endocrinol Metab 73,832-836,1991
21. KLUGBAUER S, LENGFELDER E, DEMIDCHICK EP, RABES HM. A new form of RET rearrangement in thyroid carcinomas of children after the Chernobyl accident. Oncogene 13,1099-1102,1996
22. KULIG A, LEWINSKI A, SPORNY S, SYGUT J. Cytological report from fine needle aspiration biopsy of the thyroid gland - premises and commentary (in Polish). Endokrynol Pol - Polish J Endocrinol 47(suppl. 1 to No. 1),55-63,1996
23. LEMOINE NR, MAYALL ES, STRINGER B, WYNFORD-THOMAS D. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 4,159-164,1989
24. MANENTI G, PILOTTI S, RE FC, DELLA PORTA G, PIEROTTI MA. Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas. Eur J Cancer 30A.987-993,1994
25. MASOOD S, AGUSTE L-J, WESTERBAND A, BELLUCO C, VALDERAMA E, ATTIE J. Differential oncogenic expresion in thyroid follicular and Hürthle cell carcinomas. Am J Surg 166,366-368,1993
26. MORIS CM, HAO QL, HEISTERKAMP N, FITZGERALD PH, GROFFEN J. Localization of the TRK proto-oncogene to human chromosome bands 1q23-1q24. Oncogene 6,1093-1095,1991
27. MIRANDA C, MINOLETTI F, GRECOA, Sozzi G, PIEROTTI MA. Refined localization of the human TPR gene to chromosome 1q25 by in situ hybridisation. Genomics 23,714-715,1994
28. MULLIGAN LM, ENG C, HEALEY CS, CLAYTON D, KWOK JBJ, GARDNER E, PONDER MA, FRILLING A, JACKSON CE, LEHNERT H, NEUMANN HPH, et al. Specific muatations of the RET protoncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genet 6,70-74,1994
29. MULLIGAN LM, PONDER BAJ. Genetic basis of endocrine disease: multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 80,1989-1995,1995
30. NALDINI L, VIGNA E, NARSINHAM R, GAUDINO G, ZARNEGAR R, et al. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-met. Oncogene 6,501-504,1991
31. NAMBA H, GUTMAN RA, MATSUO K, ALVAREZ A, FAGIN JA. H-ras protooncogene mutations in human thyroid neoplasms. J Clin Endocrinol Metab 71,223-229,1990
32. NIKIFOROV YE, ROWLAND JM, BOVE KE, MONFORTE-MUNOZ H, FAGIN JA. Distinct pattern of ret oncogene rearrangements in morphological variants of radiationinduced and sporadic thyroid papillary carcinomas in children. Cancer Res 57, 1690-1694, 1997
33. ORELL SR, PHILIPS J. The Thyroid: fine-needle biopsy and cytological diagnosis of thyroid lesions. In: Monographs in Clinical Cytology (Ed SR Orell), Vol. 14, Karger, Basel 1997
34. PIEROTTI MA, BONGARZONE I, BORRELLO MG, GRECOA, PILOTTI S, Sozzi G. Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells. GEnes Chromosom Cancer 16,1-14,1996
35. PIEROTTI MA, SANTORO M, JENKINS RB, Sozzi G, BONGARZONE I, et al. Characterization of an inversion on the long arm of chromosome 10 juxtaposing D 10S170 and RET and creating the oncogenic sequence RET/PTC. Proc Natl Acad Sci USA 89,1616-1620,1992
36. SANTORO M, DATHAN NA, BERLINGHERI MT, BONGARZONE I, PAULIN C, et al. Molecular characterization of RET/PTC3, a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene 9,509-516,1994
37. SHI Y., Zou M, SCHMIDT H, JUHASZ F, STENSKYV, et al. High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area. Cancer Res 51,2690-2693,1991
38. Sozzi G, BONGARZONE I, MIOZZO M, BORELLO MG, BUTTI MG, et al. A t(10;17) translocation creates the RET/ptc2 chimeric transforming sequence in papillary thyroid carcinoma. Genes Chrom Cancer 9,244-250,1994
39. Sozzi G, BONGARZONE I, MIOZZO M, CARIANI CT, MONDELLINI P, et al. Cytogenetic and molecular genetic characterization of papillary thyroid carcinomas. Genes Chromosom Cancer 5,212-218,1992
40. SPORNY S. Cytodiagnostics of Thyroid Diseases (in Polish). Studio Graficzne Sobiepanski-Trocha s.c., Lodz 1999
41. SUAREZ HG. Genetic alterations in human epithelial thyroid tumours. Clin Endocrinol 48,531-546,1998
42. SUAREZ HG, Du VILLARD JA, SEVERING M, CAILLOU B, SCHLUMBERGER M, et al. Presence of mutations in all three ras genes in human thyroid tuinors.Oncogene 5,565-570,1990
43. WEIDNER N. The Difficult Diagnosis in Surgical Pathology. W.B. Saunders, Philadelphia 1996
44. WILLIAMS ED. Mechanisms and pathogenesis of thyroid cancer in animals and man. Mutation Res 333,123-129,1995